Bcl-w Enhances Mesenchymal Changes and Invasiveness of Glioblastoma Cells by Inducing Nuclear Accumulation of β-Catenin

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lee, Woo Sang ^a   Woo, Eun Young ^a   Kwon, Junhye ^b   Park, Myung Jin ^a   Lee, Jae Seon ^a   Han, Young Hoon ^a   Bae, In Hwa ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FOCAL ADHESION KINASE; GELATINASE A; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL W; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG; VIMENTIN; APOPTOSIS REGULATORY PROTEIN; BCL2L2 PROTEIN, HUMAN; FOCAL ADHESION KINASE 1; MMP2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PTK2 PROTEIN, HUMAN; TWIST RELATED PROTEIN 1; TWIST1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GRADING; CANCER TISSUE; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; TUMOR INVASION; UPREGULATION; CELL MOTION; GENETICS; METABOLISM; NUCLEOCYTOPLASMIC TRANSPORT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

GASTROPODA;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS REGULATORY PROTEINS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; FOCAL ADHESION KINASE 1; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; TWIST-RELATED PROTEIN 1; VIMENTIN;

EID: 84879534594     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068030     Document Type: Article

References (40)

1. Molina JR, Hayashi Y, Stephens C, Georgescu MM, (2010) Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia 12: 453-463. PubMed: 20563248.
2. Hoelzinger DB, Demuth T, Berens ME, (2007) Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99: 1583-1593. doi:10.1093/jnci/djm187. PubMed: 17971532.
3. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, et al. (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7: 7-16. doi:10.1593/neo.04535. PubMed: 15720813.
4. Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, et al. (1999) Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79: 1828-1835. doi:10.1038/sj.bjc.6690291. PubMed: 10206300.
5. Le DM, Besson A, Fogg DK, Choi KS, Waisman DM, et al. (2003) Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J Neurosci 23: 4034-4043. PubMed: 12764090.
6. Markovic DS, Glass R, Synowitz M, Rooijen Nv, Kettenmann H, (2005) Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol 64: 754-762. doi:10.1097/01.jnen.0000178445.33972.a9. PubMed: 16141784.
7. Varga I, Hutoczki G, Petras M, Scholtz B, Miko E, et al. (2010) Expression of invasion-related extracellular matrix molecules in human glioblastoma versus intracerebral lung adenocarcinoma metastasis 71. Cent Eur Neurosurg. pp.: 173-180.
8. Liu C, Tu Y, Sun X, Jiang J, Jin X, et al. (2011) Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations. Clin Exp Med 11: 105-112. PubMed: 20809334.
9. Gross A, McDonnell JM, Korsmeyer SJ, (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911. doi:10.1101/gad.13.15.1899. PubMed: 10444588.
10. Gibson L, Holmgreen SP, Huang DC, Bernard O, Copeland NG, et al. (1996) bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene 13: 665-675. PubMed: 8761287.
11. Cory S, Adams JM, (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656. doi:10.1038/nrc883. PubMed: 12209154.
12. Bae IH, Park MJ, Yoon SH, Kang SW, Lee SS, et al. (2006) Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res 66: 4991-4995. doi:10.1158/0008-5472.CAN-05-4254. PubMed: 16707418.
13. Bae IH, Yoon SH, Lee SB, Park JK, Ho JN, et al. (2009) Signaling components involved in Bcl-w-induced migration of gastric cancer cells. Cancer Lett 277: 22-28. doi:10.1016/j.canlet.2008.11.022. PubMed: 19097687.
14. Le NH, Franken P, Fodde R, (2008) Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness. Br J Cancer 98: 1886-1893. doi:10.1038/sj.bjc.6604401. PubMed: 18506144.
15. Kim DK, Cho ES, Seong JK, Um HD, (2001) Adaptive concentrations of hydrogen peroxide suppress cell death by blocking the activation of SAPK/JNK pathway. J Cell Sci 114: 4329-4334. PubMed: 11739664.
16. Park MJ, Kim MS, Park IC, Kang HS, Yoo H, et al. (2002) PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res 62: 6318-6322. PubMed: 12414663.
17. Li J, Zhou BP, (2011) Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 11: 49. doi:10.1186/1471-2407-11-49. PubMed: 21284870.
18. Larue L, Bellacosa A, (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 24: 7443-7454. doi:10.1038/sj.onc.1209091. PubMed: 16288291.
19. Fodde R, Brabletz T, (2007) Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19: 150-158. doi:10.1016/j.ceb.2007.02.007. PubMed: 17306971.
20. Wu B, Crampton SP, Hughes CC, (2007) Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26: 227-239. doi:10.1016/j.immuni.2006.12.007. PubMed: 17306568.
21. Yue X, Lan F, Yang W, Yang Y, Han L, et al. (2010) Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells. Brain Res 1366: 27-37. doi:10.1016/j.brainres.2010.10.032. PubMed: 20969832.
22. Datta SR, Brunet A, Greenberg ME, (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927. doi:10.1101/gad.13.22.2905. PubMed: 10579998.
23. Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, et al. (2007) Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer 121: 1424-1432. doi:10.1002/ijc.22862. PubMed: 17551921.
24. Wang H, Wang H, Zhang W, Huang HJ, Liao WS, (2004) Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab Invest 84: 941-951. doi:10.1038/labinvest.3700123. PubMed: 15184909.
25. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463: 318-325. PubMed: 20032975.
26. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173. doi:10.1016/j.ccr.2006.02.019. PubMed: 16530701.
27. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454. doi:10.1038/nrc822. PubMed: 12189386.
28. Yang J, Weinberg RA, (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829. doi:10.1016/j.devcel.2008.05.009. PubMed: 18539112.
29. Mikheeva SA, Mikheev AM, Petit A, Beyer R, Oxford RG, et al. (2010) TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer 9: 194. doi:10.1186/1476-4598-9-194. PubMed: 20646316.
30. Yang HW, Menon LG, Black PM, Carroll RS, Johnson MD, (2010) SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer 10: 301. doi:10.1186/1471-2407-10-301. PubMed: 20565806.
31. Han SP, Kim JH, Han ME, Sim HE, Kim KS, et al. (2011) SNAI1 is involved in the proliferation and migration of glioblastoma cells. Cell Mol Neurobiol 31: 489-496. doi:10.1007/s10571-010-9643-4. PubMed: 21225336.
32. Zuo J, Ishikawa T, Boutros S, Xiao Z, Humtsoe JO, et al. (2010) Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis. Mol Cancer Res 8: 170-182. doi:10.1158/1541-7786.MCR-09-0354. PubMed: 20145039.
33. Giles RH, van Es JH, Clevers H, (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24. PubMed: 12781368.
34. Morin PJ, (1999) beta-catenin signaling and cancer. Bioessays 21: 1021-1030. doi:10.1002/(SICI)1521-1878(199912)22:1. PubMed: 10580987.
35. Polakis P, (2000) Wnt signaling and cancer. Genes Dev 14: 1837-1851. PubMed: 10921899.
36. Sareddy GR, Panigrahi M, Challa S, Mahadevan A, Babu PP, (2009) Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int 55: 307-317. doi:10.1016/j.neuint.2009.03.016. PubMed: 19576519.
37. Kamino M, Kishida M, Kibe T, Ikoma K, Iijima M, et al. (2011) Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2. Cancer Sci 102: 540-548. doi:10.1111/j.1349-7006.2010.01815.x. PubMed: 21205070.
38. Nelson WJ, Nusse R, (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487. doi:10.1126/science.1094291. PubMed: 15001769.
39. Kikuchi A, Kishida S, Yamamoto H, (2006) Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 38: 1-10. PubMed: 16520547.
40. Harris TJ, Peifer M, (2005) Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol 15: 234-237. doi:10.1016/j.tcb.2005.03.002. PubMed: 15866026.